General Information of Drug Formulation (ID: F19735)

Formulation Name
Saxagliptin 5 mg tablet
Company
AstraZeneca; Cardinal Health; E.R. Squibb & Sons; Physicians Total Care
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Saxagliptin DMGXENV Type-2 diabetes 5A11 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carmellose sodium E00625 Not Available Disintegrant
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant